Papers

1

Total Citations

3

H-Index

1

About

Dr. Lijuan Liao is a pioneering researcher at the intersection of gastroenterology, microbiology, and surgical oncology, with a primary focus on *Helicobacter pylori* pathogenesis and advanced hepatobiliary surgery. Her seminal work on linolenic acid-metronidazole conjugates demonstrated a novel oxidative mechanism for inhibiting *H. pylori* growth, offering a promising therapeutic avenue against antibiotic-resistant strains. This study, published in 2023, has already garnered 3 citations, reflecting its immediate relevance in the field of antimicrobial resistance. Beyond microbiology, Dr. Liao has made significant contributions to the advancement of robotic liver resection (RLR), authoring a landmark consensus statement that established standardized protocols for this minimally invasive technique. Her work has been instrumental in demonstrating the benefits of RLR—including reduced blood loss and shorter hospital stays—while addressing ongoing controversies in surgical practice. With a career marked by translational research that bridges basic science and clinical application, Dr. Liao continues to shape both the treatment of gastric infections and the evolution of robotic surgery, making her a vital figure in modern hepatobiliary and gastrointestinal medicine.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Linolenic acid-metronidazole inhibits the growth of <i>Helicobacter pylori</i> through oxidation
3 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Affiliated Hospital of Youjiang Medical University for Nationalities

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago